Volitionrx — Fact Sheet (June 2025)

1 slide from Volitionrx's fact sheet, June 2025

Slide 1: VolitionRx One Pager: Epigenetic Early Detection Tests
Commercial launches worldwide in animal health (2022-2024); human products NYSE:VNRX to follow Combined TAM Our mission is to save lives and improve >$10 billion outcomes for millions of people and animals worldwide by advancing low-cost, epigenetic early detection and treatment monitoring tests. De